1. RET TKI: Potential Role in Thyroid Cancers

   • Alessandro Antonelli
   • Poupak Fallahi
   • Clodoveo Ferri

   Evolving Therapies (RM Bukowski, Section Editor) 28 January 2012 Pages: 97 - 104

2. The Biology and Clinical Features of Non–small Cell Lung Cancers with EML4-ALK Translocation

   • Rathi N. Pillai
   • Suresh S. Ramalingam

   Evolving Therapies (RM Bukowski, Section Editor) 05 February 2012 Pages: 105 - 110

3. FGF Receptor Inhibitors: Role in Cancer Therapy

   • Gennaro Daniele
   • Jesus Corral
   • Johann S. de Bono

   Evolving Therapies (RM Bukowski, Section Editor) 05 February 2012 Pages: 111 - 119

   

4. Survivin in Solid Tumors: Rationale for Development of Inhibitors

   • David N. Church
   • Denis C. Talbot

   Evolving Therapies (RM Bukowski, Section Editor) 12 January 2012 Pages: 120 - 128

5. PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies

   • Lise Willems
   • Jerome Tamburini
   • Didier Bouscary

   Evolving Therapies (RM Bukowski, Section Editor) 17 February 2012 Pages: 129 - 138

   

6. Current Progress in Adaptive Radiation Therapy for Head and Neck Cancer

   • David L. Schwartz

   Head and Neck Cancers (EY Hanna, Section Editor) 11 February 2012 Pages: 139 - 147

   

7. Robotic Surgery for Oropharynx Cancer: Promise, Challenges, and Future Directions

   • John R. de Almeida
   • Eric M. Genden

   Head and Neck Cancers (EY Hanna, Section Editor) 05 February 2012 Pages: 148 - 157

   

8. Functional Outcomes after Chemoradiotherapy of Laryngeal and Pharyngeal Cancers

   • Katherine A. Hutcheson
   • Jan S. Lewin

   Head and Neck Cancers (EY Hanna, Section Editor) 17 January 2012 Pages: 158 - 165

9. Salivary Gland Cancers: Biology and Molecular Targets for Therapy

   • Diana Bell
   • Ehab Y. Hanna

   Head and Neck Cancers (EY Hanna, Section Editor) 14 January 2012 Pages: 166 - 174

   

10. The Clinical Importance of Quality-of-Life Scores in Patients with Skull Base Tumors: A Meta-Analysis and Review of the Literature

    • Moran Amit
    • Avraham Abergel
    • Ziv Gil

    Head and Neck Cancers (EY Hanna, Section Editor) 27 January 2012 Pages: 175 - 181

    

11. Late Effects in Cancer Survivors: “The Shared Care Model”

    • Aziza Shad
    • Scott N. Myers
    • Karen Hennessy

    Pediatric Oncology (S Epelman, Section Editor) 28 January 2012 Pages: 182 - 190

12. End-of-Life Management in Pediatric Cancer

    • Claudia L. Epelman

    Pediatric Oncology (S Epelman, Section Editor) 17 February 2012 Pages: 191 - 196

13. Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents

    • Patrick A. Thompson
    • Murali Chintagumpala

    Pediatric Oncology (S Epelman, Section Editor) 03 February 2012 Pages: 197 - 205

    

14. Impact of Molecular Biology Studies on the Understanding of Brain Tumors in Childhood

    • Amulya A. Nageswara Rao
    • Roger J. Packer

    Pediatric Oncology (S Epelman, Section Editor) 13 January 2012 Pages: 206 - 212

15. Preserving Vision in Retinoblastoma Through Early Detection and Intervention

    • Sidnei Epelman

    Pediatric Oncology (S Epelman, Section Editor) 21 February 2012 Pages: 213 - 219

16. Erratum to: New Drug Developments for Patients with Metastatic Soft Tissue Sarcoma

    • Jörg Thomas Hartmann
    • Shreyaskumar Patel

    Retraction Note 28 February 2012 Pages: 220 - 220